tbuckley/cabot-search huggingface dataset:
Erratum
Journal: British Journal of Sports Medicine (1985)

Council of EuropeIn May 1985 a seminar on "Sport and Physical Education in Primary Schools" was held in Bilbao, Northern Spain.Emphasis was placed on the need to fit the programme to the physical and psychological needs of the children, the need for general and PE teachers to appreciate this, in initial or in-service training, and to pay special attention to the less physically gifted.There is need for international collaboration, and for research into the needs of the primary school child (DS-PE
DETAIL MEN
Authors: George E. Moore
Journal: JAMA (1960)

<h3>To the Editor:—</h3> InThe Journal, Aug. 13, page 1655, Austin Smith, M.D., stated, "Detail men form an indispensable link between the doctor and new knowledge that can help or save a patient," and, "In a few minutes the detail man can acquaint the doctor with the capacities and the limitations of a new drug." This just is not possible. Most detail men do not have an adequate background for evaluating therapeutic agents. What is the source of their information? Are they capable of sorting out the pertinent and statistically meaningful results of animal studies and preliminary human trials of a new drug? How can they know enough about the subtle differences in the structures of similar compounds that are being sold by rival companies? The busy practitioner grasps this weak crutch because of the difficulty of finding and evaluating medical reports scattered through a dozen journals. Medical meetings are
Applied Physiology
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
'Alter' a virus molecularly for polio vaccine?
Authors: C. Marwick
Journal: JAMA (1992)

THE MOLECULAR biology of the poliomyelitis virus is becoming so well known that it now is possible to think of molecularly altering polioviruses for vaccines. It appears to be the general opinion of many researchers (attending an international workshop on the neurovirulence of poliovirus held by the Food and Drug Administration in Bethesda, Md) that such viruses (for vaccine use) are not likely to be available in the near future. But when they are, they might be less sensitive to temperature changes in storage and hence provide improved protection. <h3>30-Year History</h3> Thus, it appears that the molecular-level analysis of mutations in wild-type poliovirus developed more than 30 years ago from the live-virus polio vaccine by Albert Sabin, MD, now are beginning to bear fruit. At the workshop, Sabin said: "The scientific challenge is to look at the genetic elements of neurovirulence and see whether these can be deleted without interfering
The Cover
Authors: M. Therese Southgate
Journal: JAMA (1992)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Journal of Investigative Dermatology, Baltimore
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Title
Authors: Caroline Meade, Connor Drake, Ralph Snyderman
Journal: JAMA (2016)

its goal of substantially improving the nation's health without changes in how care is delivered.Health care continues to be financially incentivized to deliver expensive specialty care for the sporadic treatment of disease rather than health promotion and effective primary and secondary prevention.As a consequence, the burden of preventable chronic diseases continues to rise.Accountable care organizations were created to improve care delivery by encouraging comprehensive care delivery networks and by tying reimbursement to quality outcomes.Although this aspect of the ACA recognizes the need to deliver quality care that improves health outcomes, accountable care organizations currently provide care for only 8.9% of the population 2 and changes in reimbursement to reward better outcomes have been slow.Rational delivery models to provide personalized, preventive, and participatory care, such as personalized health care 3,4 and other evidencebased approaches developed through funding by the Patient-Centered Outcomes Resource Institute, 5 will not be embraced by health care systems until reimbursement supports their adoption.The benefits that could be provided by the implementation of proactive and patient-centered delivery models are thus stifled by the financial losses that they would incur within the current fee-for-service payment model.Therefore, improvements the ACA has made by expanding coverage may not result in better health until significant progress is made in value-based reimbursement.We believe that supporting care delivery reform to prevent disease and improve health outcomes must now become a number one priority, and reimbursement reform is needed to achieve this.Health care systems are capable of innovating and developing more effective models of care, but they will not do so until they are reimbursed appropriately.Changing the financial incentives to encourage the adoption of innovations in care could markedly expand any benefits the ACA already provides.
The hyperimmunoglobulinaemia E and recurrent infections syndrome in an adult
Authors: R Lewis
Journal: Thorax (1990)

for a 52 year old plumber with extensive malignant pleural mesothelioma, who had been admitted with impaired consciousness and left sided long tract signs and whose computed tomogram showed at least four cerebral metastases, two in the brainstem and two in the right partietal region.Both of these tumours were subsequently confirmed at necropsy.In addition, there was extensive tumour affecting the pericardium, epicardium, and myocardium and extending exten- sively through the peritoneum.
From the NIH: Family history information enables physicians to recognize genetically 'at risk' patients
Journal: JAMA (1980)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Intravenous Alimentation
Authors: H. E. Magee
Journal: BMJ (1948)

Although penicillin can now be expected to control the infection in about 90% of patients, a closer inspection of our results shows several features which are far from satis- factory and which reveal our ignorance of several important aspects of this disease: (a) In the majority of patients who relapse no good reason can be given for the failure of penicillin; in only a few could it be explained on the basis of a highly resistant organism.(b) The remarkably high incidence of heart failure, both during and soon after apparently effective treatment, is not explained.(c) The presence in the heart valves of what appeared to be living organisms in about one-third of patients who died after apparently effective treatment suggests that dormant infec- tion may be an important sequel of treatment with penicillin. .For these and other reasons we believe that further intensive research on this disease is indicated, with particu- lar emphasis on higher dosage and on careful analysis of post-mortem material.The following centres are continu- ing this work, and it is hoped that an adequate number of patients will be referred to them: Belfast (Queen'
The Legitimacy of Neurasthenia
Authors: Valentina M. Vielma
Journal: JAMA (1994)

<h3>To the Editor.</h3> —In his interesting In Perspective on neurasthenia, Dr Martensen<sup>1</sup>omits depression as a latter-day explanation for "living on a plane lower than normal." While depressive disorder was certainly recognized a century ago<sup>2</sup>and distinguished from neurasthenia, as recently as 1973 a leading psychiatric textbook noted that "[m]oderate depression is the rule" in neurasthenia.<sup>3</sup>Today, one sees an increasing number of patients seeking antidepressant medication for increasingly mild or vague symptoms—fatigue, exhaustion, weariness, mild headache, premenstrual syndrome, poor concentration, grumpiness, even a messy desktop. What Love<sup>4</sup>and Beard called neurasthenia, we sometimes call minor depression, dysthymia, depression not otherwise specified, or adjustment disorder with depressed mood. And when a patient denies depression but has symptoms of hypochondriasis, somatoform disorder, or even chronic fatigue, one also considers treatment with antidepressants. While Love and Beard called neurasthenia a disorder of the "upper crust," Hollingshead and Redlich
An Immunosuppressive Role for Eya3 in TNBC
Journal: Cancer Discovery (2018)

A recent study indicates that the protein Eya3 influences the adaptive immune response to promote tumor growth, not only decreasing the number of tumor-infiltrating CD8+ T cells, but also driving their exhaustion through PD-L1 upregulation. These findings could spur new strategies to treat triple-negative breast cancer, which currently lacks targeted therapies.
Spinal Fusion Evaluated in Herniated Lumbar Discs
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Day-care quality and quantity become challenges for parents, politicians, and medical researchers
Authors: J. W. Zylke
Journal: JAMA (1988)

A FEW YEARS ago, day care was rarely discussed on Capitol Hill. But by last fall, it had become a major issue in the presidential campaign. There seems to be no doubt in political circles that the question of day care is not one of "if" but of "how" and "how much." Unlike the politicians, day care was heatedly discussed among psychologists a few years ago. Today, although disagreements remain, consensus has been reached on some issues. <h3>Quality and Stability</h3> Experts agree that children can do well with high-quality, stable supplemental care. Researchers are still debating the significance of existing research data, while uniformly calling for additional data to sort out the myriad of factors that have an impact on an infant's development. Little debate exists over supplemental care for children over ages 2 1/2 to 3 years old. A long experience with nursery and preschools has provided ample evidence
Canadian Drugs
Authors: Mike Mitka
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Steroids in sports: after four decades, time to return these genies to bottle?
Authors: V. Cowart
Journal: JAMA (1987)

IN THE AFTERMATH of the first postseason drug testing by the National Collegiate Athletic Association (NCAA), two things are apparent. Many college football players see nothing wrong with taking anabolic steroids, either from a health or ethical stand-point, and, evidently, little is known about these drugs' effects. The most publicized of the more than 20 collegiate athletes from at least seven universities who were barred from participation in postseason bowl games because they had used steroids was All-America linebacker Brian Bosworth of the University of Oklahoma. At a press conference, Bosworth criticized the NCAA and said: "Steroids are a legal drug. I'll continue to fight against the abuse of drugs—recreational drugs that are destroying society. Steroids aren't destroying society." Several of the athletes whose steroid use was detected said they took them for injuries, primarily knee injuries. These statements seemed to indicate that not only were they eager to make
Surveillance of leishmaniases in France, 1999 to 2012
Authors: L Lachaud, JP Dedet, P Marty, F Faraut, P Buffet, JP Gangneux, C Ravel, P Bastien, C Working Group for the Notification
Journal: Eurosurveillance (2013)

Leishmaniasis is endemic in the south of France, where autochthonous disease is caused by Leishmania infantum, and affects both humans and dogs. The prevalence of canine leishmaniasis is between 3 and 66% depending on the region and the methods used. Human leishmaniases are also imported into France, mainly from French Guiana and North Africa. The surveillance of autochthonous and imported human leishmaniases is based on passive notification to the National Reference Centre for Leishmaniases (NRCL) created in 1998. Between 1999 and 2012, 317 autochthonous and 1,154 imported cases were notified to the NRCL. The average number of autochthonous cases notified per year was 22.6, mainly cases of visceral leishmaniasis (84.5%). All cases were infected in the south of France. Leishmaniasis incidence is 0.22 per 100,000 inhabitants in the endemic area. Imported cases were more frequent (annual mean of 82.4 cases) and consisted predominantly in cutaneous leishmaniasis (CL) cases (91%), essentially L. major CL imported from Maghreb and Sub-Saharan Africa, and L. guyanensis CL from French Guiana. This national notification system allowed a better understanding of the incidence and distribution of the disease; it is also useful to assess the temporal-spatial evolution of the disease in France, which appears relatively stable.
EDITOR'S NOTE: Re: Benefits and Risks of Screening Mammography for Women in Their Forties: a Statistical Appraisal
Journal: JNCI Journal of the National Cancer Institute (1999)

Journal policy that all authors are specifically asked to disclose any financial arrangements that may raise the question of bias in the work presented, including direct and indirect arrangements that benefit their institutions or departments.Our purpose in soliciting such information is to allow readers to judge the opinions of authors and reported results of studies in the context of any potential conflicts of interest.Readers can then make their own judgement about the relevance of the authors' disclosures.Similar to most-if not all-biomedical journals, we rely on authors to reveal potential conflicts of interest fully.As is the case with other journals, we lack the resources-both monetary and humanto investigate the completeness and accuracy of the information provided.
A College Textbook of Hygiene
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Leaders attempt a long-term prognosis for the health of American medicine
Authors: M. F. Goldsmith
Journal: JAMA (1988)

"MEDICINE FOR THE 21st Century" is emblazoned over the entrance of the Annenberg Center in Rancho Mirage, Calif, making the palmy high-tech oasis an apt location for a recent conference on that theme. More than 100 leaders of medicine, industry, and government were invited to consider how future health care needs of the American people will be met, given a present state of affairs many see as threatening the very foundation of the system—biomedical research and technological innovation and development. At the conference, cosponsored by the American Medical Association (AMA), the Annenberg Center for Health Sciences at Eisenhower, and Pfizer, Inc, a major concern was that diminished financial support for basic research is driving prospective scientists into other careers and is making the United States less competitive internationally. At the same time, intensive challenges to long-held US supremacy in biotechnology and medicine are starting to come from western Europe and
VENOUS THROMBOEMBOLISM AND RISK OF RECURRENCE: A DANISH NATIONWIDE COHORT STUDY
Authors: Ida Ehlers Albertsen, Lars Hvilsted Rasmussen, Thure Filskov Overvad, Mette Søgaard, Peter Brønnum Nielsen, Samuel Z. Goldhaber, Torben Bjerregaard Larsen
Journal: Journal of the American College of Cardiology (2018)
Personal view
Authors: I. Clarke
Journal: BMJ (1993)

vears dripped silently on to his lap and I realised that he was weeping.I moved closer and put my arm around him.He covered his face with his hand but the tears continued to fall.As he fumbled to dry his eyes with the corner of his shirt I gave him my handkerchief.There was nothing I could say; I was fighting to keep control myself.Ando said something which I could not pick up and I bent closer."I will be missing you," he repeated.It was so characteristic of the man to say something like that and it rent my heart.It was my first experience of telling someone that he had AIDS;